Document is current
Any future updates will be listed below
-
Authors
Price, W. Nicholson II http://orcid.org/0000-0003-0729-290X
Sendak, Mark http://orcid.org/0000-0001-5828-4497
Balu, Suresh
Singh, Karandeep http://orcid.org/0000-0001-8980-2330
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF17SA027784)
Gordon and Betty Moore Foundation (GBMF10849, GBMF10849)
- License Information
-
More Information
Article History
First Online: 9 August 2023
Competing interests
: W.N.P. declares no competing interests. M.P.S. is a co-inventor of intellectual property licensed by Duke University to Clinetic, Inc., KelaHealth, Inc. and Cohere-Med, Inc. M.P.S. holds equity in Clinetic, Inc. S.B. is a co-inventor of intellectual property licensed by Duke University to Clinetic, Inc. and Cohere-Med, Inc. K.S.’s institution receives grant funding from the US National Institute of Diabetes and Digestive and Kidney Diseases, Blue Cross Blue Shield of Michigan and Teva Pharmaceuticals for unrelated work. K.S. previously served on a scientific advisory board for Flatiron Health and received consulting fees.
